Trials / Completed
CompletedNCT04072328
Propofol vs. Midazolam With Propofol for Sedative Endoscopy in Patients With Previous Paradoxical Reaction to Midazolam
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- DongGuk University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is to compare propofol vs. midazolam with propofol for sedative endoscopy in patients with previous paradoxical reaction to midazolam. Patients who meet eligibility criteria will randomly assigned to propofol group or midazolam with propofol group. Then they will receive a sedative endoscopy with close monitoring. The primary outcome is the prevalence of paradoxical response during endoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propofol | Propofol will be given 0.5 mg/kg bolus initially, and can be administered additionally after a least 30 secs if necessary. |
| DRUG | Midazolam | midazolam with propofol |
Timeline
- Start date
- 2018-10-19
- Primary completion
- 2020-08-10
- Completion
- 2020-12-20
- First posted
- 2019-08-28
- Last updated
- 2020-12-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04072328. Inclusion in this directory is not an endorsement.